O-BRIDGE: Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction

Sponsor
AZ Sint-Jan AV (Other)
Overall Status
Recruiting
CT.gov ID
NCT02661139
Collaborator
(none)
55
1
174
0.3

Study Details

Study Description

Brief Summary

The investigators aim to develop a prospective database in which patient demographics, surgical, dental, prosthetic and QOL parameters collected during consecutive visits within the framework of routine practice, are being registered for each oncological patient eligible for (immediate/delayed) fixed prosthodontic rehabilitation at time of oral cavity reconstruction

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The number of patients requiring major ablative surgery in the oral cavity, including partial/radical mandibular or maxillary resection, due to a head and neck carcinoma, osteoradionecrosis (ORN), or medication-related osteonecrosis of the jaw (MRONJ) has not been accurately reported. Surgical reconstruction to restore oral function and aesthetics forms a challenge to maxillofacial surgeons, and greatly impacts patient' quality of life (QOL). Recently, an active collaboration between the surgeons of the Oral and Maxillofacial Surgery Unit and the prosthodontist (LB) of the Department of Dentistry at the General Hospital Saint-John Bruges led to the development of the "Oncology-bridge (O-bridge)" protocol, which offers (immediate/delayed) fixed prosthetic rehabilitation in a minimum of sessions and a strongly reduced two-week treatment time, consequently accelerating patient' improved QOL at a considerably reduced cost.

    The investigators aim to develop a prospective database in which patient demographics, surgical, dental, prosthetic and QOL parameters collected during consecutive visits within the framework of routine practice, are being registered for each oncological patient eligible for (immediate/delayed) fixed prosthodontic rehabilitation at time of oral cavity reconstruction This could provide the investigators with more information about potential patient, surgical and prosthetic factors influencing short- and long-term biological and mechanical stability, as well as patient QOL. Moreover, registration of those results could function as a measurement of quality of care, and could be used for sample size calculation for future large prospective trials.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    55 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction
    Study Start Date :
    Jun 1, 2013
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2027

    Outcome Measures

    Primary Outcome Measures

    1. implant survival rate [within 12 months postoperative]

    2. bone resorption, as evaluated with cone-beam computed tomography [within 12 months postoperative]

    3. prosthesis survival rate [within 12 months postoperative]

    4. implant survival rate [within 60 months postoperative]

    5. bone resorption, as evaluated with cone-beam computed tomography [within 60 months postoperative]

    6. prosthesis survival rate [within 60 months postoperative]

    Secondary Outcome Measures

    1. Prevalence of oncological patients requiring jaw reconstruction secondary to tumour resection, ORN or MRONJ [within 12 months postoperative]

    2. Potential biologic or mechanical risk factors predictive of undesirable functional or aesthetic outcomes, through regression analysis [within 60 months postoperative]

    3. Patient' quality of life after prosthetic rehabilitation [until a maximum of 60 months follow-up]

    Other Outcome Measures

    1. patient satisfaction, as measured through visual analogue scale [until a maximum of 60 months follow-up]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients of all ages

    • Patients of all genders

    • Patients with a histologically or clinically confirmed diagnosis of ORN, MRONJ, as classified by Ruggiero et al. (Ruggiero, et al., 2014) or carcinoma located in the oral cavity and jawbone, requiring segmental or total jaw resection

    • Patients eligible for jaw and oral cavity reconstruction combined with immediate/delayed implant loading for fixed prosthetic rehabilitation

    • Patients not eligible for conventional removable prosthetic rehabilitation

    Exclusion Criteria:
    • Patients with a clinically confirmed diagnosis of osteonecrosis not related to an oncological diagnosis or treatment

    • Patients with medical contraindications for jaw reconstruction combined with immediate implant loading for fixed prosthetic rehabilitation

    • Patients eligible for conventional removable prosthetic rehabilitation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 General Hospital Saint-John Bruges Bruges Belgium

    Sponsors and Collaborators

    • AZ Sint-Jan AV

    Investigators

    • Principal Investigator: Johan Abeloos, MD, Department of Oral and Maxillofacial Surgery, General Hospital Saint-John Bruges, Bruges, Belgium

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Johan Abeloos, Maxillofacial surgeon, Head of Department, AZ Sint-Jan AV
    ClinicalTrials.gov Identifier:
    NCT02661139
    Other Study ID Numbers:
    • B049201525496
    First Posted:
    Jan 22, 2016
    Last Update Posted:
    Feb 28, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Johan Abeloos, Maxillofacial surgeon, Head of Department, AZ Sint-Jan AV
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 28, 2022